Suppr超能文献

难治性室性心动过速患者的晚期程控电刺激结果及胺碘酮治疗的长期电生理效应

Results of late programmed electrical stimulation and long-term electrophysiologic effects of amiodarone therapy in patients with refractory ventricular tachycardia.

作者信息

Veltri E P, Reid P R, Platia E V, Griffith L S

出版信息

Am J Cardiol. 1985 Feb 1;55(4):375-9. doi: 10.1016/0002-9149(85)90379-0.

Abstract

Thirteen patients with refractory, recurrent, life-threatening ventricular tachycardia (VT) underwent electrophysiologic testing before and after long-term amiodarone therapy. Nine patients (69%) had coronary artery disease, 3 (23%) had nonischemic cardiomyopathy and 1 patient (8%) had mitral valve prolapse. At control electrophysiologic study, programmed electrical stimulation (PES) induced VT in all patients: sustained VT in 11 and nonsustained VT in 2 (9 beats and 31 beats). After oral loading with amiodarone, 1200 mg/day for 14 days, followed by maintenance therapy with 408 +/- 20 mg/day (mean +/- standard error of the mean), repeat PES at 6 +/- 1.6 months revealed inducible VT in 12 of 13 patients: sustained VT in 11 and nonsustained VT (32 beats) in 1 patient. Inducible VT was suppressed in only 1 patient. Amiodarone significantly increased sinus cycle length, PR interval, QRS duration and right ventricular effective refractory period. Insignificant increases in AH, HV and QTc intervals were noted. At 24 +/- 2 months, 8 patients (62%) (all with inducible VT at late PES) were free of clinical arrhythmic events (syncope or sudden death), compared with 5 patients (38%) (4 with inducible VT at late PES) with events. There were no significant differences in the induced VT cycle length, VT cycle length change, ease of inducibility or hemodynamic response to induced VT at late PES in patients with and without arrhythmic events.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

13例难治性、复发性、危及生命的室性心动过速(VT)患者在长期胺碘酮治疗前后接受了电生理检查。9例患者(69%)患有冠状动脉疾病,3例(23%)患有非缺血性心肌病,1例患者(8%)患有二尖瓣脱垂。在对照电生理研究中,程序电刺激(PES)在所有患者中均诱发了VT:11例为持续性VT,2例为非持续性VT(分别为9次和31次搏动)。口服胺碘酮负荷剂量,1200mg/天,共14天,随后以408±20mg/天(平均值±平均值标准误差)进行维持治疗,在6±1.6个月时重复PES,结果显示13例患者中有12例可诱发VT:11例为持续性VT,1例为非持续性VT(32次搏动)。仅1例患者的可诱发VT得到抑制。胺碘酮显著增加了窦性周期长度、PR间期、QRS时限和右心室有效不应期。AH、HV和QTc间期有不显著增加。在24±2个月时,8例患者(62%)(均在后期PES时可诱发VT)无临床心律失常事件(晕厥或猝死),而有事件的患者为5例(38%)(4例在后期PES时可诱发VT)。有无心律失常事件的患者在后期PES时诱发的VT周期长度、VT周期长度变化、诱发难易程度或对诱发VT的血流动力学反应方面无显著差异。(摘要截断于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验